TacticGem LLC - Dec 9, 2024 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
10%+ Owner
Signature
/s/ Karthik Radhakrishnan, Attorney-in-fact
Stock symbol
MNPR
Transactions as of
Dec 9, 2024
Transactions value $
$0
Form type
4
Date filed
12/17/2024, 04:57 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNPR Common Stock Other $0 -1.43M -100% $0.00 0 Dec 9, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

TacticGem LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Tactic Gem, LLC distributed 611,079 shares to Gem Pharmaceuticals, LLC and 822,255 shares to Tactic Pharma, LLC for no consideration.